Table: Sawai Pharmaceutical -Q1 group results (IFRS)

SAWAI group

06/08/2019 07:00

Aug 6 (Reuters)- 
              Sawai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales               47.13               45.30           184.40    
                   (+4.1 pct)          (+18.7 pct)      (+0.0 pct)  
  Operating            8.89                7.32            25.80    
                   (+21.4 pct)         (+11.0 pct)      (+0.0 pct)  
  Pretax               8.90                7.35            25.70    
                   (+21.1 pct)         (+2.1 pct)       (+0.1 pct)  
  Net                  6.44                5.26            19.20    
                   (+22.4 pct)         (-6.5 pct)       (-0.9 pct)  
  EPS Basic        147.02 yen          120.12 yen       438.59 yen  
  EPS Diluted      146.92 yen          120.04 yen                   
  Ann Div                              135.00 yen       130.00 yen  
  -Q2 Div                               65.00 yen        65.00 yen  
  -Q4 Div                               70.00 yen        65.00 yen  
 
  NOTE - Sawai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T